Guidelines for Reasonable and Appropriate Care in the Emergency Department (GRACE‐4): Alcohol use disorder and cannabinoid hyperemesis syndrome management in the emergency department
Academic Emergency Medicine · 2024-05 · 31 (5) · 425-455
DOI: 10.1111/acem.14911 ↗Kurz gefasst
Leitlinie in der Zeitschrift Academic Emergency Medicine, online erschienen am 15.05.2024. Verfasst von Bjug Borgundvaag und 15 weiteren Autor:innen. Beteiligte Einrichtung: Schwartz/Reisman Emergency Medicine Institute, Sinai Health System, Department of Family and Community Medicine, University of Toronto, Toronto, Onta…. Hauptthemen laut MEDLINE: Emergency Service, Hospital, Alcoholism. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 143 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Society for Academic Emergency Medicine.
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
The fourth Society for Academic Emergency Medicine (SAEM) Guidelines for Reasonable and Appropriate Care in the Emergency Department (GRACE‐4) is on the topic of the emergency department (ED) management of nonopioid use disorders and focuses on alcohol withdrawal syndrome (AWS), alcohol use disorder (AUD), and cannabinoid hyperemesis syndrome (CHS). The SAEM GRACE‐4 Writing Team, composed of emergency physicians and experts in addiction medicine and patients with lived experience, applied the Grading of Recommendations Assessment Development and Evaluation (GRADE) approach to assess the certainty of evidence and strength of recommendations regarding six priority questions for adult ED patients with AWS, AUD, and CHS. The SAEM GRACE‐4 Writing Team reached the following recommendations: (1) in adult ED patients (over the age of 18) with moderate to severe AWS who are being admitted to hospital, we suggest using phenobarbital in addition to benzodiazepines compared to using benzodiazepines alone [ low to very low certainty of evidence ]; (2) in adult ED patients (over the age of 18) with AUD who desire alcohol cessation, we suggest a prescription for one anticraving medication [ very low certainty of evidence ]; (2a) in adult ED patients (over the age of 18) with AUD, we suggest naltrexone (compared to no prescription) to prevent return to heavy drinking [ low certainty of evidence ]; (2b) in adult ED patients (over the age of 18) with AUD and contraindications to naltrexone, we suggest acamprosate (compared to no prescription) to prevent return to heavy drinking and/or to reduce heavy drinking [ low certainty of evidence ]; (2c) in adult ED patients (over the age of 18) with AUD, we suggest gabapentin (compared to no prescription) for the management of AUD to reduce heavy drinking days and improve alcohol withdrawal symptoms [ very low certainty of evidence ]; (3a) in adult ED patients (over the age of 18) presenting to the ED with CHS we suggest the use of haloperidol or droperidol (in addition to usual care/serotonin antagonists, e.g., ondansetron) to help with symptom management [ very low certainty of evidence ]; and (3b) in adult ED patients (over the age of 18) presenting to the ED with CHS, we also suggest offering the use of topical capsaicin (in addition to usual care/serotonin antagonists, e.g., ondansetron) to help with symptom management [ very low certainty of evidence ].
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Schwartz/Reisman Emergency Medicine Institute, Sinai Health System, Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada.
- Department of Emergency Medicine, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Emergency Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
- Department of Emergency Medicine, University of California Los Angeles, Los Angeles, California, USA.
- Department of Medicine, Division of Critical & Emergency Medicine, McMaster University, Hamilton, Ontario, Canada.
- The Ronald O. Perelman Department of Emergency Medicine, Division of Medical Toxicology, New York University Grossman School of Medicine, New York, New York, USA.
ORCID-Profile: Bjug Borgundvaag, Fernanda Bellolio, Isabelle Miles, Evan S Schwarz, Sameer Sharif, Mark K Su, Kevin Baumgartner, David B Liss, Hasan Sheikh, Jody Vogel, Emily B Austin, Suneel Upadhye, Michelle Klaiman, Christopher R Carpenter
Förderung
- Society for Academic Emergency Medicine
Zitieren
APA
Borgundvaag, B., Bellolio, F., Miles, I., Schwarz, E. S., Sharif, S., Su, M. K., Baumgartner, K., Liss, D. B., Sheikh, H., Vogel, J., Austin, E. B., Upadhye, S., Klaiman, M., Vellend, R., Munkley, A., & Carpenter, C. R. (2024). Guidelines for Reasonable and Appropriate Care in the Emergency Department (GRACE‐4): Alcohol use disorder and cannabinoid hyperemesis syndrome management in the emergency department. Academic Emergency Medicine, 31(5), 425-455. https://doi.org/10.1111/acem.14911
Vancouver
Borgundvaag B, Bellolio F, Miles I, Schwarz ES, Sharif S, Su MK, et al. Guidelines for Reasonable and Appropriate Care in the Emergency Department (GRACE‐4): Alcohol use disorder and cannabinoid hyperemesis syndrome management in the emergency department. Academic Emergency Medicine. 2024;31(5):425-455. doi:10.1111/acem.14911
BibTeX
@article{Borgundvaag2024,
author = {Borgundvaag, Bjug and Bellolio, Fernanda and Miles, Isabelle and Schwarz, Evan S and Sharif, Sameer and Su, Mark K and Baumgartner, Kevin and Liss, David B and Sheikh, Hasan and Vogel, Jody and Austin, Emily B and Upadhye, Suneel and Klaiman, Michelle and Vellend, Robert and Munkley, Anna and Carpenter, Christopher R},
title = {Guidelines for Reasonable and Appropriate Care in the Emergency Department (GRACE‐4): Alcohol use disorder and cannabinoid hyperemesis syndrome management in the emergency department},
journal = {Academic Emergency Medicine},
year = {2024},
volume = {31},
number = {5},
pages = {425--455},
doi = {10.1111/acem.14911}
}
EUVIMED